Deep supervised learning using self-adaptive auxiliary loss for COVID-19 diagnosis from imbalanced CT images

Deep learning with noisy labels in medical prediction problems: a scoping review

OBJECTIVES

Medical research faces substantial challenges from noisy labels attributed to factors like inter-expert variability and machine-extracted labels. Despite this, the adoption of label noise management remains limited, and label noise is largely ignored. To this end, there is a critical need to conduct a scoping review focusing on the problem space. This scoping review aims to comprehensively review label noise management in deep learning-based medical prediction problems, which includes label noise detection, label noise handling, and evaluation. Research involving label uncertainty is also included.

METHODS

Our scoping review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched 4 databases, including PubMed, IEEE Xplore, Google Scholar, and Semantic Scholar. Our search terms include "noisy label AND medical/healthcare/clinical," "uncertainty AND medical/healthcare/clinical," and "noise AND medical/healthcare/clinical."

RESULTS

A total of 60 papers met inclusion criteria between 2016 and 2023. A series of practical questions in medical research are investigated. These include the sources of label noise, the impact of label noise, the detection of label noise, label noise handling techniques, and their evaluation. Categorization of both label noise detection methods and handling techniques are provided.

DISCUSSION

From a methodological perspective, we observe that the medical community has been up to date with the broader deep-learning community, given that most techniques have been evaluated on medical data. We recommend considering label noise as a standard element in medical research, even if it is not dedicated to handling noisy labels. Initial experiments can start with easy-to-implement methods, such as noise-robust loss functions, weighting, and curriculum learning.

DeepGAMI: deep biologically guided auxiliary learning for multimodal integration and imputation to improve genotype-phenotype prediction

BACKGROUND

Genotypes are strongly associated with disease phenotypes, particularly in brain disorders. However, the molecular and cellular mechanisms behind this association remain elusive. With emerging multimodal data for these mechanisms, machine learning methods can be applied for phenotype prediction at different scales, but due to the black-box nature of machine learning, integrating these modalities and interpreting biological mechanisms can be challenging. Additionally, the partial availability of these multimodal data presents a challenge in developing these predictive models.

METHOD

To address these challenges, we developed DeepGAMI, an interpretable neural network model to improve genotype-phenotype prediction from multimodal data. DeepGAMI leverages functional genomic information, such as eQTLs and gene regulation, to guide neural network connections. Additionally, it includes an auxiliary learning layer for cross-modal imputation allowing the imputation of latent features of missing modalities and thus predicting phenotypes from a single modality. Finally, DeepGAMI uses integrated gradient to prioritize multimodal features for various phenotypes.

RESULTS

We applied DeepGAMI to several multimodal datasets including genotype and bulk and cell-type gene expression data in brain diseases, and gene expression and electrophysiology data of mouse neuronal cells. Using cross-validation and independent validation, DeepGAMI outperformed existing methods for classifying disease types, and cellular and clinical phenotypes, even using single modalities (e.g., AUC score of 0.79 for Schizophrenia and 0.73 for cognitive impairment in Alzheimer's disease).

CONCLUSION

We demonstrated that DeepGAMI improves phenotype prediction and prioritizes phenotypic features and networks in multiple multimodal datasets in complex brains and brain diseases. Also, it prioritized disease-associated variants, genes, and regulatory networks linked to different phenotypes, providing novel insights into the interpretation of gene regulatory mechanisms. DeepGAMI is open-source and available for general use.

A Systematic Review on Deep Structured Learning for COVID-19 Screening Using Chest CT from 2020 to 2022

The emergence of the COVID-19 pandemic in Wuhan in 2019 led to the discovery of a novel coronavirus. The World Health Organization (WHO) designated it as a global pandemic on 11 March 2020 due to its rapid and widespread transmission. Its impact has had profound implications, particularly in the realm of public health. Extensive scientific endeavors have been directed towards devising effective treatment strategies and vaccines. Within the healthcare and medical imaging domain, the application of artificial intelligence (AI) has brought significant advantages. This study delves into peer-reviewed research articles spanning the years 2020 to 2022, focusing on AI-driven methodologies for the analysis and screening of COVID-19 through chest CT scan data. We assess the efficacy of deep learning algorithms in facilitating decision making processes. Our exploration encompasses various facets, including data collection, systematic contributions, emerging techniques, and encountered challenges. However, the comparison of outcomes between 2020 and 2022 proves intricate due to shifts in dataset magnitudes over time. The initiatives aimed at developing AI-powered tools for the detection, localization, and segmentation of COVID-19 cases are primarily centered on educational and training contexts. We deliberate on their merits and constraints, particularly in the context of necessitating cross-population train/test models. Our analysis encompassed a review of 231 research publications, bolstered by a meta-analysis employing search keywords (COVID-19 OR Coronavirus) AND chest CT AND (deep learning OR artificial intelligence OR medical imaging) on both the PubMed Central Repository and Web of Science platforms.

Cov-TransNet: Dual branch fusion network with transformer for COVID-19 infection segmentation

Segmentation of COVID-19 infection is a challenging task due to the blurred boundaries and low contrast between the infected and the non-infected areas in COVID-19 CT images, especially for small infection regions. COV-TransNet is presented to achieve high-precision segmentation of COVID-19 infection regions in this paper. The proposed segmentation network is composed of the auxiliary branch and the backbone branch. The auxiliary branch network adopts transformer to provide global information, helping the convolution layers in backbone branch to learn specific local features better. A multi-scale feature attention module is introduced to capture contextual information and adaptively enhance feature representations. Specially, a high internal resolution is maintained during the attention calculation process. Moreover, feature activation module can effectively reduce the loss of valid information during sampling. The proposed network can take full advantage of different depth and multi-scale features to achieve high sensitivity for identifying lesions of varied sizes and locations. We experiment on several datasets of the COVID-19 lesion segmentation task, including COVID-19-CT-Seg, UESTC-COVID-19, MosMedData and COVID-19-MedSeg. Comprehensive results demonstrate that COV-TransNet outperforms the existing state-of-the-art segmentation methods and achieves better segmentation performance for multi-scale lesions.

Comparison of Convolutional Neural Networks and Transformers for the Classification of Images of COVID-19, Pneumonia and Healthy Individuals as Observed with Computed Tomography

In this work, the performance of five deep learning architectures in classifying COVID-19 in a multi-class set-up is evaluated. The classifiers were built on pretrained ResNet-50, ResNet-50r (with kernel size 5×5 in the first convolutional layer), DenseNet-121, MobileNet-v3 and the state-of-the-art CaiT-24-XXS-224 (CaiT) transformer. The cross entropy and weighted cross entropy were minimised with Adam and AdamW. In total, 20 experiments were conducted with 10 repetitions and obtained the following metrics: accuracy (Acc), balanced accuracy (BA), F₁ and F₂ from the general Fβ macro score, Matthew’s Correlation Coefficient (MCC), sensitivity (Sens) and specificity (Spec) followed by bootstrapping. The performance of the classifiers was compared by using the Friedman–Nemenyi test. The results show that less complex architectures such as ResNet-50, ResNet-50r and DenseNet-121 were able to achieve better generalization with rankings of 1.53, 1.71 and 3.05 for the Matthew Correlation Coefficient, respectively, while MobileNet-v3 and CaiT obtained rankings of 3.72 and 5.0, respectively.

A lightweight CNN-based network on COVID-19 detection using X-ray and CT images

BACKGROUND AND OBJECTIVES

The traditional method of detecting COVID-19 disease mainly rely on the interpretation of computer tomography (CT) or X-ray images (X-ray) by doctors or professional researchers to identify whether it is COVID-19 disease, which is easy to cause identification mistakes. In this study, the technology of convolutional neural network is expected to be able to efficiently and accurately identify the COVID-19 disease.

METHODS

This study uses and fine-tunes seven convolutional neural networks including InceptionV3, ResNet50V2, Xception, DenseNet121, MobileNetV2, EfficientNet-B0, and EfficientNetV2 on COVID-19 detection. In addition, we proposes a lightweight convolutional neural network, LightEfficientNetV2, on small number of chest X-ray and CT images. Five-fold cross-validation was used to evaluate the performance of each model. To confirm the performance of the proposed model, LightEfficientNetV2 was carried out on three different datasets (NIH Chest X-rays, SARS-CoV-2 and COVID-CT).

RESULTS

On chest X-ray image dataset, the highest accuracy 96.50% was from InceptionV3 before fine-tuning; and the highest accuracy 97.73% was from EfficientNetV2 after fine-tuning. The accuracy of the LightEfficientNetV2 model proposed in this study is 98.33% on chest X-ray image. On CT images, the best transfer learning model before fine-tuning is MobileNetV2, with an accuracy of 94.46%; the best transfer learning model after fine-tuning is Xception, with an accuracy of 96.78%. The accuracy of the LightEfficientNetV2 model proposed in this study is 97.48% on CT image.

CONCLUSIONS

Compared with the SOTA, LightEfficientNetV2 proposed in this study demonstrates promising performance on chest X-ray images, CT images and three different datasets.

Gradient-based Optimization Algorithm for Hybrid Loss Function in Low-dose CT Denoising

Deep learning techniques have emerged in de-noising low-dose computed tomography (CT) images to avoid the potential health risks of high ionizing radiation dose on patients. Although these post-processing methods display high quality denoised images, the denoising performance still has the potential to improve. The primary purpose of this work was to determine and analyze the most effective and efficient hybrid loss function in deep learning (DL)-based denoising network. Objective functions in deep learning algorithms are the main keys for optimizing the parameters of a network and can affect the quality of the denoised image significantly. Hence, this work examined the various combinations of the most common objective functions in CT denoising networks, namely L1 loss, per-pixel loss, perceptual loss, and structural dissimilarity loss. Further, a hyperparameter learning algorithm was also introduced to find the best scalable factors of the loss functions in each hybrid loss function combination. For simplic-ity, RED-CNN was used in this study to easily demonstrate the performance of the losses during the denoising process. Based on this experiment, the balance between these loss function via the gradient-based optimization algorithm could help in the generalizability prediction of designing future CT denoising networks.

A privacy-aware method for COVID-19 detection in chest CT images using lightweight deep conventional neural network and blockchain

With the global spread of the COVID-19 epidemic, a reliable method is required for identifying COVID-19 victims. The biggest issue in detecting the virus is a lack of testing kits that are both reliable and affordable. Due to the virus's rapid dissemination, medical professionals have trouble finding positive patients. However, the next real-life issue is sharing data with hospitals around the world while considering the organizations' privacy concerns. The primary worries for training a global Deep Learning (DL) model are creating a collaborative platform and personal confidentiality. Another challenge is exchanging data with health care institutions while protecting the organizations' confidentiality. The primary concerns for training a universal DL model are creating a collaborative platform and preserving privacy. This paper provides a model that receives a small quantity of data from various sources, like organizations or sections of hospitals, and trains a global DL model utilizing blockchain-based Convolutional Neural Networks (CNNs). In addition, we use the Transfer Learning (TL) technique to initialize layers rather than initialize randomly and discover which layers should be removed before selection. Besides, the blockchain system verifies the data, and the DL method trains the model globally while keeping the institution's confidentiality. Furthermore, we gather the actual and novel COVID-19 patients. Finally, we run extensive experiments utilizing Python and its libraries, such as Scikit-Learn and TensorFlow, to assess the proposed method. We evaluated works using five different datasets, including Boukan Dr. Shahid Gholipour hospital, Tabriz Emam Reza hospital, Mahabad Emam Khomeini hospital, Maragheh Dr.Beheshti hospital, and Miandoab Abbasi hospital datasets, and our technique outperform state-of-the-art methods on average in terms of precision (2.7%), recall (3.1%), F1 (2.9%), and accuracy (2.8%).

Supervised and weakly supervised deep learning models for COVID-19 CT diagnosis: A systematic review

Artificial intelligence (AI) and computer vision (CV) methods become reliable to extract features from radiological images, aiding COVID-19 diagnosis ahead of the pathogenic tests and saving critical time for disease management and control. Thus, this review article focuses on cascading numerous deep learning-based COVID-19 computerized tomography (CT) imaging diagnosis research, providing a baseline for future research. Compared to previous review articles on the topic, this study pigeon-holes the collected literature very differently (i.e., its multi-level arrangement). For this purpose, 71 relevant studies were found using a variety of trustworthy databases and search engines, including Google Scholar, IEEE Xplore, Web of Science, PubMed, Science Direct, and Scopus. We classify the selected literature in multi-level machine learning groups, such as supervised and weakly supervised learning. Our review article reveals that weak supervision has been adopted extensively for COVID-19 CT diagnosis compared to supervised learning. Weakly supervised (conventional transfer learning) techniques can be utilized effectively for real-time clinical practices by reusing the sophisticated features rather than over-parameterizing the standard models. Few-shot and self-supervised learning are the recent trends to address data scarcity and model efficacy. The deep learning (artificial intelligence) based models are mainly utilized for disease management and control. Therefore, it is more appropriate for readers to comprehend the related perceptive of deep learning approaches for the in-progress COVID-19 CT diagnosis research.

Time series predicting of COVID-19 based on deep learning

COVID-19 was declared a global pandemic by the World Health Organisation (WHO) on 11th March 2020. Many researchers have, in the past, attempted to predict a COVID outbreak and its effect. Some have regarded time-series variables as primary factors which can affect the onset of infectious diseases like influenza and severe acute respiratory syndrome (SARS). In this study, we have used public datasets provided by the European Centre for Disease Prevention and Control for developing a prediction model for the spread of the COVID-19 outbreak to and throughout Malaysia, Morocco and Saudi Arabia. We have made use of certain effective deep learning (DL) models for this purpose. We assessed some specific major features for predicting the trend of the existing COVID-19 outbreak in these three countries. In this study, we also proposed a DL approach that includes recurrent neural network (RNN) and long short-term memory (LSTM) networks for predicting the probable numbers of COVID-19 cases. The LSTM models showed a 98.58% precision accuracy while the RNN models showed a 93.45% precision accuracy. Also, this study compared the number of coronavirus cases and the number of resulting deaths in Malaysia, Morocco and Saudi Arabia. Thereafter, we predicted the number of confirmed COVID-19 cases and deaths for a subsequent seven days. In this study, we presented their predictions using the data that was available up to December 3rd, 2020.

Exploiting probability density function of deep convolutional autoencoders' latent space for reliable COVID-19 detection on CT scans

We present a probabilistic method for classifying chest computed tomography (CT) scans into COVID-19 and non-COVID-19. To this end, we design and train, in an unsupervised manner, a deep convolutional autoencoder (DCAE) on a selected training data set, which is composed only of COVID-19 CT scans. Once the model is trained, the encoder can generate the compact hidden representation (the hidden feature vectors) of the training data set. Afterwards, we exploit the obtained hidden representation to build up the target probability density function (PDF) of the training data set by means of kernel density estimation (KDE). Subsequently, in the test phase, we feed a test CT into the trained encoder to produce the corresponding hidden feature vector, and then, we utilise the target PDF to compute the corresponding PDF value of the test image. Finally, this obtained value is compared to a threshold to assign the COVID-19 label or non-COVID-19 to the test image. We numerically check our approach's performance (i.e. test accuracy and training times) by comparing it with those of some state-of-the-art methods.

Deep learning based pipelines for Alzheimer's disease diagnosis: A comparative study and a novel deep-ensemble method

BACKGROUND

Alzheimer's disease is a chronic neurodegenerative disease that destroys brain cells, causing irreversible degeneration of cognitive functions and dementia. Its causes are not yet fully understood, and there is no curative treatment. However, neuroimaging tools currently offer help in clinical diagnosis, and, recently, deep learning methods have rapidly become a key methodology applied to these tools. The reason is that they require little or no image preprocessing and can automatically infer an optimal representation of the data from raw images without requiring prior feature selection, resulting in a more objective and less biased process. However, training a reliable model is challenging due to the significant differences in brain image types.

METHODS

We aim to contribute to the research and study of Alzheimer's disease through computer-aided diagnosis (CAD) by comparing different deep learning models. In this work, there are three main objectives: i) to present a fully automated deep-ensemble approach for dementia-level classification from brain images, ii) to compare different deep learning architectures to obtain the most suitable one for the task, and (iii) evaluate the robustness of the proposed strategy in a deep learning framework to detect Alzheimer's disease and recognise different levels of dementia. The proposed approach is specifically designed to be potential support for clinical care based on patients' brain images.

RESULTS

Our strategy was developed and tested on three MRI and one fMRI public datasets with heterogeneous characteristics. By performing a comprehensive analysis of binary classification (Alzheimer's disease status or not) and multiclass classification (recognising different levels of dementia), the proposed approach can exceed state of the art in both tasks, reaching an accuracy of 98.51% in the binary case, and 98.67% in the multiclass case averaged over the four different data sets.

CONCLUSION

We strongly believe that integrating the proposed deep-ensemble approach will result in robust and reliable CAD systems, considering the numerous cross-dataset experiments performed. Being tested on MRIs and fMRIs, our strategy can be easily extended to other imaging techniques. In conclusion, we found that our deep-ensemble strategy could be efficiently applied for this task with a considerable potential benefit for patient management.

Application of Artificial Intelligence in COVID-19 Diagnosis and Therapeutics

The coronavirus disease 2019 (COVID-19) pandemic began at the end of December 2019, giving rise to a high rate of infections and causing COVID-19-associated deaths worldwide. It was first reported in Wuhan, China, and since then, not only global leaders, organizations, and pharmaceutical/biotech companies, but also researchers, have directed their efforts toward overcoming this threat. The use of artificial intelligence (AI) has recently surged internationally and has been applied to diverse aspects of many problems. The benefits of using AI are now widely accepted, and many studies have shown great success in medical research on tasks, such as the classification, detection, and prediction of disease, or even patient outcome. In fact, AI technology has been actively employed in various ways in COVID-19 research, and several clinical applications of AI-equipped medical devices for the diagnosis of COVID-19 have already been reported. Hence, in this review, we summarize the latest studies that focus on medical imaging analysis, drug discovery, and therapeutics such as vaccine development and public health decision-making using AI. This survey clarifies the advantages of using AI in the fight against COVID-19 and provides future directions for tackling the COVID-19 pandemic using AI techniques.

Deep Learning for COVID-19 Diagnosis from CT Images

COVID-19, an infectious coronavirus disease, caused a pandemic with countless deaths. From the outset, clinical institutes have explored computed tomography as an effective and complementary screening tool alongside the reverse transcriptase-polymerase chain reaction. Deep learning techniques have shown promising results in similar medical tasks and, hence, may provide solutions to COVID-19 based on medical images of patients. We aim to contribute to the research in this field by: (i) Comparing different architectures on a public and extended reference dataset to find the most suitable; (ii) Proposing a patient-oriented investigation of the best performing networks; and (iii) Evaluating their robustness in a real-world scenario, represented by cross-dataset experiments. We exploited ten well-known convolutional neural networks on two public datasets. The results show that, on the reference dataset, the most suitable architecture is VGG19, which (i) Achieved 98.87% accuracy in the network comparison; (ii) Obtained 95.91% accuracy on the patient status classification, even though it misclassifies some patients that other networks classify correctly; and (iii) The cross-dataset experiments exhibit the limitations of deep learning approaches in a real-world scenario with 70.15% accuracy, which need further investigation to improve the robustness. Thus, VGG19 architecture showed promising performance in the classification of COVID-19 cases. Nonetheless, this architecture enables extensive improvements based on its modification, or even with preprocessing step in addition to it. Finally, the cross-dataset experiments exposed the critical weakness of classifying images from heterogeneous data sources, compatible with a real-world scenario.